175 related articles for article (PubMed ID: 31773422)
1. Design and optimization of film-forming gel of etoricoxib using research surface methodology.
Parhi R; Goli VVN
Drug Deliv Transl Res; 2020 Apr; 10(2):498-514. PubMed ID: 31773422
[TBL] [Abstract][Full Text] [Related]
2. Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology.
Parhi R; Suresh P
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():331-41. PubMed ID: 26478318
[TBL] [Abstract][Full Text] [Related]
3. Application of Response Surface Methodology for Design and Optimization of Reservoir-type Transdermal Patch of Simvastatin.
Parhi R; Suresh P; Patnaik S
Curr Drug Deliv; 2016; 13(5):742-53. PubMed ID: 26452533
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
Patel NA; Patel NJ; Patel RP
Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
[TBL] [Abstract][Full Text] [Related]
5. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
[TBL] [Abstract][Full Text] [Related]
6. Tailoring the mucoadhesive and sustained release characteristics of mesalamine loaded formulations for local treatment of distal forms of ulcerative colitis.
Ali HS; Hanafy AF; El Achy SN
Eur J Pharm Sci; 2016 Oct; 93():233-43. PubMed ID: 27503459
[TBL] [Abstract][Full Text] [Related]
7. Formulation and ex vivo evaluation of rofecoxib gel for topical application.
Das MK; Ahmed AB
Acta Pol Pharm; 2007; 64(5):461-7. PubMed ID: 18540168
[TBL] [Abstract][Full Text] [Related]
8. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
9. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
10. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Kalita B; Das MK; Sarma M; Deka A
AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
[TBL] [Abstract][Full Text] [Related]
11. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
12. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
13. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
[TBL] [Abstract][Full Text] [Related]
15. PEG-PLGA- hybrid nanoparticles loaded with etoricoxib - phospholipid complex for effective treatment of inflammation in rat model.
Dave V; Srivastava P; Tak K; Sharma S
J Microencapsul; 2019 May; 36(3):236-249. PubMed ID: 31092089
[TBL] [Abstract][Full Text] [Related]
16. Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design.
Chaudhary H; Kohli K; Amin S; Rathee P; Kumar V
J Pharm Sci; 2011 Feb; 100(2):580-93. PubMed ID: 20669331
[TBL] [Abstract][Full Text] [Related]
17. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
Hiremath PS; Saha RN
Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
[TBL] [Abstract][Full Text] [Related]
18. Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.
Rao PR; Chalasani KB; Chauhan AS; Jain AK; Diwan PV; Ram MK
Drug Deliv; 2006; 13(3):207-13. PubMed ID: 16556573
[TBL] [Abstract][Full Text] [Related]
19. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
Shahzad Y; Khan Q; Hussain T; Shah SN
Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
[TBL] [Abstract][Full Text] [Related]
20. Development of ibuprofen nanoliposome for transdermal delivery: Physical characterization, in vitro/in vivo studies, and anti-inflammatory activity.
Gaur PK; Bajpai M; Mishra S; Verma A
Artif Cells Nanomed Biotechnol; 2016; 44(1):370-5. PubMed ID: 25211229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
